Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know
Why QuidelOrtho (QDEL) Stock Is Down Today
QDEL Q3 Deep Dive: Margin Progress and Cost Actions Offset Headwinds in Core Diagnostics
QuidelOrtho (NASDAQ:QDEL) Beats Q3 Sales Expectations
―  Total revenue of $700 million; excluding COVID-19 and Donor Screening, revenue grew mid-single digits, demonstrating solid underlying growth and momentum ―
QuidelOrtho (QDEL) Q3 Earnings: What To Expect
Clearance expands menu and enables high-sensitivity troponin I measurement to aid in the diagnosis of myocardial infarction
SAN DIEGO , Oct. 23, 2025 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, has released Episode 52 of its Science Bytes podcast, featuring George...
1 Small-Cap Stock with Exciting Potential and 2 We Avoid